FDA: New Steps to improve Supply Chain Security

Recommendation
9 September 2025
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
The FDA supports the adoption of more modern technologies for improving the security of the drug supply chain. Innovations should improve tracking and tracing of medicines.
Now FDA is launching a new pilot project in which participants representing the drug supply chain (e.g., manufacturers, repackagers and other stakeholders) can pilot the use of innovative and emerging approaches for enhanced tracing and verification. Currently the project is focusing on prescription drugs in the U.S., with the aim to prevent suspicious and illegitimate products from entering the supply chain.
The intention of the so-called "Pilot Project Program Under the Drug Supply Chain Security Act" (DSCSA Pilot Project Program) is to assist FDA and members of the pharmaceutical distribution supply chain in the development of an electronic, interoperable system.
Related GMP News
15.07.2025New Swissmedic Technical Interpretation on Returns of Medicinal Products
15.07.2025Two new GDP Non-Compliance Reports from Austria and Ireland published in the EudraGMDP database
15.07.2025Reminder: Participate in the GDP Implementation Survey until 31 July 2025
15.07.2025PDA Publishes Results of Transportation Validation Benchmarking Survey
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms